Redeye returns with smaller near-term forecast adjustments following a Q3'25 report that was largely in line with expectations. The current takeover offering from Telia will remain the key price driver, and we reiterate our view that the offering will likely go through.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/